Oncotron 2mg Injection


Product Info

Prescription required Yes
Marketer Sun Pharmaceutical Industries Ltd
Active Ingredient Mitoxantrone (2mg)
Storage Store below 30°C
Chemical ClassAnthracenedione Derivative
Habit FormingNo
Therapeutic ClassANTI NEOPLASTICS
Action ClassAlkaloids-cytotoxic agents
User Rating4.2
User Reviews681

FAQ

Oncotron 2mg Injection Reviews

Oncotron 2mg is used in the treatment of certain kinds of breast and blood cancers. It is usually given alone or in together with certain other medicines as part of combination chemotherapy. It prevents cancer cells from growing, as a result of which they eventually die.

Oncotron 2mg is given as an injection into vein under the supervision of a doctor and should not be self-administered. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include anemia (low number of red blood cells), decreased white blood cell count, increased bleeding tendency, infection, nausea, and vomiting. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them.

Inform your doctor if you have a medical history, of bleeding disorders, heart or liver disease, radiation treatment or any infection. Inform your doctor immediately if you notice unusual bruising or bleeding or if you have dark, tarry, or bloody stools.  This medicine is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with kidney, liver and heart function during treatment with this medicine. Use of effective contraception by both males and females during treatment is important to avoid pregnancy.

How Oncotron 2mg Injection Works

Oncotron 2mg is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.

How to Use Oncotron 2mg Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Benefits of Oncotron 2mg Injection

  • In Blood cancer: Blood cancer, also called leukemia, is a cancer of the blood-forming tissues that decreases the body's ability to fight infection. Oncotron 2mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
  • In Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a cancer of the white blood cells in our body, also called mantle-cell lymphoma. White blood cells are those cells that help us to fight infections. Oncotron 2mg helps to restrict cancer growth and also blocks the action of other chemicals that are required for cancer growth and further spread. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to.
  • In Breast cancer: Oncotron 2mg helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Oncotron 2mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.

Uses of Oncotron 2mg Injection

  • Non-Hodgkin lymphoma (NHL)
  • Blood cancer
  • Breast cancer

Oncotron 2mg Injection Side Effects

Item form

Safety Tips

Alcohol  CAUTION
Caution is advised when consuming alcohol with Oncotron 2mg. Please consult your doctor.
Breast feeding  UNSAFE
Oncotron 2mg is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Liver  SAFE IF PRESCRIBED
Oncotron 2mg is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Oncotron 2mg may not be needed in these patients. Please consult your doctor.
Driving  UNSAFE
Oncotron 2mg may cause side effects which could affect your ability to drive.Oncotron 2mg can have a minor effect on your ability to drive. This is caused by the possible side effects, such as confusion or feeling tired
Pregnancy  CONSULT YOUR DOCTOR
Oncotron 2mg is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Kidney  SAFE IF PRESCRIBED
Oncotron 2mg is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Oncotron 2mg may not be needed in these patients. Please consult your doctor.

Quick Tips

  • Oncotron 2mg is given as an injection into veins under the supervision of a doctor.

References

  1. Medscape. Mixantrone.
  2. Mitoxantrone. Rockland, Massachusetts: EMD Serono; 2012.
  3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 932-33.
  4. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Mitoxantrone. [Updated 2018 Oct 31].
  5. Central Drugs Standard Control Organisation (CDSCO).
  6. Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 952.
  7. Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1715.

Other Medical Preparations